Retrospective case–control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer-Reference-Cited by-同舟云学术

Retrospective case–control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer

Published:2024-01-12 Issue:4 Volume:42 Page:391-397
ISSN:1867-1071
Container-title:Japanese Journal of Radiology
language:en
Short-container-title:Jpn J Radiol

Author:

Watanabe Ken^ORCID,Igarashi Takao,Uchiyama Mayuki,Ishigaki Takayuki,Ojiri Hiroya

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11604-023-01517-9.pdf

Reference12 articles.

1. YuJiao D, HongTao L, Meng W, Na L, Tian T, Ying W, et al. Global burden of thyroid cancer from 1990 to 2017. JAMA Netw Open. 2020;3(6):e208759. https://doi.org/10.1001/jamanetworkopen.2020.8759.

2. Anna S, Kullathorn T, Melissa B, Lehana T, George B, Hertzel G. Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab. 2004;89(8):3668–76. https://doi.org/10.1210/jc.2003-031167.

3. Bryan H, Erik A, Keith B, Gerard D, Susan M, Yuri N, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. https://doi.org/10.1089/thy.2015.0020.

4. Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery. Thyroid Tumor Clinical Practice Guideline 2018. http://jaes.umin.jp/pdf/guideline2018.pdf (in Japanese). Last Accessed 13 Feb 2022

5. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88(4):1433–41. https://doi.org/10.1210/jc.2002-021702.